Spots Global Cancer Trial Database for AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial Tumors
Official Title: Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study
Study ID: NCT05679089
Conditions
Interventions
Study Description
Brief Summary: ASCEND-BRAIN is a prospective, observational study aimed at early-detection of intracranial tumors by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 358 participants including intracranial malignant tumors, patients with benign disorders of central nervous system and healthy participants.
Detailed Description:
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Zhujiang Hospital, Guangzhou, Guangdong, China
Contact Details
Name: Hongbo Guo, MD,Ph.D
Affiliation: Zhujiang Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
